An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS. Some patients experienced unprecedented functional recovery, offering new hope in a previously devastating diagnosis.
Superintendent Pharmacist Carolina Goncalves explores various factors impacting brain health, covering ways individuals can optimise their brain health as well as the latest developments in neuroscience research.
A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
A collaboration between the University of Michigan and Stanford University aims to give stroke victims the ability to 'speak' using brain implant technology.
A new study has found that consuming eight or more alcoholic drinks per week is associated with signs of brain injury, including damage to small blood vessels and markers related to memory and thinking problems.
A new study by researchers at the National Institute of Health (NIH) revealed their new four-dimensional brain map. This new way of brain mapping reveals how multiple sclerosis (MS) develops and how brain tissue may repair itself.
For nearly a century, medical experts have known that individuals who suffer brain trauma, such as traumatic brain injury (TBI), are at an increased risk of developing dementia later in life.
The European Brain Council is a non-profit organization dedicated to promoting brain research and improving the lives of the estimated 179 million Europeans living with brain conditions. Here, they discuss efforts aimed at enhancing care and raising awareness about brain health in Europe.
Jules Knight, Consultant Admiral Nurse for Young Onset Dementia at Dementia UK, tells us about the prevalence of young onset dementia and some of the challenges that people living with dementia can face.
A second groundbreaking drug for Alzheimer's disease has been rejected for widespread use by the NHS in England; according to the drugs spending watchdog, the drug known as Donanemab does not offer sufficient value for money.
Recently awareness surrounding head injuries and concussions has grown significantly. This has raised concerns and questions about individuals and families.
